Ticker

NUVL

Nuvalent, Inc.

4 catalysts on file

NUVL

Nuvalent, Inc.

Phase 1 AI-extracted

zidesamtinib

ROS1-positive solid tumors

80d ago ~ Jun 2, 2026

SEC 8-K verified 2mo ago

Countdown card →

NUVL

Nuvalent, Inc.

Catalyst Confirmed

neladalkib

ALK-positive NSCLC

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

NUVL

Nuvalent, Inc.

PDUFA Confirmed

zidesamtinib

ROS1-positive NSCLC

T-minus 28 days Sep 18, 2026

SEC 8-K verified 2mo ago

Countdown card →

NUVL

Nuvalent, Inc.

Catalyst Confirmed

zidesamtinib

ROS1-positive NSCLC

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →